Article in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
16 authors.
María José Muñoz-GómezUnidad de Infección Viral e Inmunidad, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, 28222 Madrid, Spain.ORCID 0000-0002-9244-4500
Pablo RyanCentro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Marta Quero-DelgadoUnidad de Infección Viral e Inmunidad, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, 28222 Madrid, Spain.
María Martin-VicenteUnidad de Infección Viral e Inmunidad, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, 28222 Madrid, Spain.ORCID 0000-0001-9148-1476
Samuel ManzanoServicio de Medicina Interna, Hospital Universitario Infanta Leonor, 28031 Madrid, Spain.ORCID 0009-0009-1355-8576
Juan Ignacio LazoServicio de Urgencias, Hospital Universitario Infanta Leonor, 28031 Madrid, Spain.ORCID 0000-0002-7562-2010
Vicente MasUnidad de Biología Viral, Centro Nacional de Microbiología, Instituto de Salud Carlos III, 28222 Madrid, Spain.
Mónica VázquezUnidad de Biología Viral, Centro Nacional de Microbiología, Instituto de Salud Carlos III, 28222 Madrid, Spain.
Daniel Sepúlveda-CrespoUnidad de Infección Viral e Inmunidad, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, 28222 Madrid, Spain.ORCID 0000-0002-8053-6045
Juan Torres-MachoServicio de Medicina Interna, Hospital Universitario Infanta Leonor, 28031 Madrid, Spain.ORCID 0000-0002-8860-6837
Isidoro MartínezUnidad de Infección Viral e Inmunidad, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, 28222 Madrid, Spain.ORCID 0000-0002-9949-9264
Salvador ResinoUnidad de Infección Viral e Inmunidad, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, 28222 Madrid, Spain.ORCID 0000-0001-8783-0450
Funding
Centro de Investigación Biomédica en Red (CIBER) de Enfermedades Infecciosas. CB21/13/00044'Miguel Servet' researcher from ISCIII CP23CIII/00004
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Antibody Response Against SARS-CoV-2 Spike Protein in People with HIV After COVID-19 Vaccination. · full record | Socratic